Diagnosing Albright’s disease, also known as McCune-Albright syndrome, requires careful evaluation across multiple body systems because symptoms vary widely from person to person and can affect bones, skin, and hormone-producing glands in different combinations.

Introduction: Who Should Seek Diagnosis

Anyone who notices unusual skin markings on a child, especially light brown patches with irregular borders appearing at or shortly after birth, should consider having the child evaluated by a healthcare provider. These patches, known as café-au-lait spots, are often the first visible sign of McCune-Albright syndrome and typically appear on one side of the body rather than spreading evenly across both sides.^[1]

Parents should also seek medical attention if their child experiences unexpectedly early signs of puberty, particularly in girls. When a girl as young as two years old begins menstrual bleeding before developing breasts or pubic hair, this unusual pattern suggests something beyond typical early puberty and warrants thorough investigation.^[2]

Bone problems provide another important reason to pursue diagnosis. If a child suffers frequent fractures from minor injuries that wouldn’t normally cause broken bones, or if bones appear deformed or grow unevenly on one side of the body, these signs point toward possible fibrous dysplasia, a key feature of the condition where scar-like tissue replaces normal bone.^[3]

Sometimes the condition remains hidden until later in childhood or even beyond. Children who seem healthy in all respects may only reveal symptoms as they grow. The severity of symptoms and how a child will be affected throughout life is difficult to predict at first, which makes ongoing monitoring important even when initial concerns seem minor.^[12]

Classic Diagnostic Methods

Diagnosing McCune-Albright syndrome requires looking for at least two of three classic features: fibrous dysplasia in bones, café-au-lait skin spots, and hormone-related abnormalities. Because the condition presents differently in each person, healthcare providers must carefully examine multiple body systems.^[6]

Physical Examination

The diagnostic process typically begins with a thorough physical examination. Doctors look for the characteristic café-au-lait spots on the skin, which are flat, oval-shaped patches with jagged, irregular borders often compared to the coastline of Maine. These differ from similar spots in other conditions, which have smooth borders more like the California coastline. The spots typically appear on the abdomen or back and usually stay on one side of the midline of the body.^[3]

Healthcare providers also examine bone structure during the physical exam. They check for facial asymmetry, uneven leg length that might cause limping, abnormal curvature of the spine called scoliosis, or any visible bone deformities. When bones in the skull and jaw are affected, they can create uneven facial features that become more noticeable as the child grows.^[1]

Imaging Studies for Bone Evaluation

To identify fibrous dysplasia and understand which bones are affected, several imaging techniques prove essential. Regular X-rays serve as the starting point, revealing areas where abnormal fibrous tissue has replaced healthy bone. These images show characteristic patterns that experienced radiologists can recognize as fibrous dysplasia.^[13]

More detailed imaging with computed tomography (CT) scans helps doctors see the full extent of bone involvement, particularly in the skull and facial bones. CT scans of the temporal bone and digital radiography photography provide clear pictures of bone structure and help identify which specific areas need monitoring or treatment.^[14]

Magnetic resonance imaging (MRI) offers another valuable tool, especially for examining bones in the skull base and understanding how fibrous dysplasia might affect nearby structures. MRI scans can reveal early changes in bone that haven’t yet become visible on regular X-rays.^[13]

Endocrine System Testing

Because McCune-Albright syndrome affects hormone-producing glands, comprehensive blood tests measure various hormone levels throughout the body. These tests check thyroid function, as about 50 percent of affected individuals produce excessive amounts of thyroid hormone, leading to hyperthyroidism with symptoms like fast heart rate, high blood pressure, weight loss, and tremors.^[1]

Doctors also measure sex hormones to evaluate for early puberty. In girls, elevated estrogen levels combined with clinical signs of puberty before age eight suggest the hormone imbalances characteristic of the condition. Blood tests also check for excess growth hormone, which can cause acromegaly, a condition marked by enlarged hands, feet, and distinctive facial features.^[1]

Testing for phosphorus levels in the blood helps identify phosphate wasting, another complication of the condition. Low phosphorus levels, known as hypophosphatemia, can occur when abnormal bone tissue produces excessive amounts of a hormone called fibroblastic growth factor-23 that causes the kidneys to lose phosphate.^[4]

Ultrasound imaging of the ovaries in girls helps detect cysts that produce excess estrogen and trigger early menstruation. These cysts typically come and go on their own, but identifying them helps confirm the diagnosis and guides treatment decisions.^[8]

Additional Diagnostic Tests

When bone abnormalities appear severe or unusual, doctors may perform a biopsy, removing a small sample of bone tissue for examination under a microscope. This procedure helps distinguish fibrous dysplasia from other bone conditions and can rule out rare cases where the abnormal tissue becomes cancerous, though this happens in fewer than one percent of people with the condition.^[1]

Various specialists may conduct additional examinations depending on which body systems show symptoms. Eye doctors check vision if skull bones near the eyes are affected. Hearing tests evaluate whether bone changes near the ears have impaired hearing. Heart rhythm monitoring may be needed if thyroid problems affect heart function.^[13]

Genetic Testing

Genetic testing can identify mutations in the GNAS gene, which causes McCune-Albright syndrome. However, finding this mutation isn’t always straightforward because it occurs as a somatic mutation, meaning it appears in only some cells rather than all cells throughout the body. This pattern, called mosaicism, means the mutation might not show up in standard blood tests.^[4]

When doctors strongly suspect the condition based on clinical features but genetic testing of blood doesn’t reveal the mutation, they may test tissue samples from affected areas like bone or skin where the mutation is more likely to be present. However, many diagnoses proceed based on clinical findings alone without genetic confirmation, since the mutation can be difficult to detect even when present.^[7]

Genetic counseling helps families understand that McCune-Albright syndrome is not inherited from parents. The mutation occurs spontaneously during early embryonic development, and affected individuals don’t pass it to their children. The risk for siblings is the same as for the general population.^[7]

Distinguishing From Similar Conditions

Healthcare providers must carefully distinguish McCune-Albright syndrome from other conditions that share some similar features. Several genetic disorders can cause café-au-lait spots, early puberty, or bone abnormalities, but each has unique characteristics that help doctors tell them apart.^[5]

For example, while both McCune-Albright syndrome and neurofibromatosis cause café-au-lait spots, the spots in neurofibromatosis have smooth borders and appear on both sides of the body, not just one side. Early puberty in McCune-Albright syndrome is gonadotropin-independent, meaning it doesn’t respond to the brain signals that normally control puberty, unlike central precocious puberty which does respond to those signals.^[10]

Diagnostics for Clinical Trial Qualification

When considering enrollment in clinical trials studying McCune-Albright syndrome, researchers require specific diagnostic criteria to ensure participants truly have the condition and to create consistent study groups. These standards help scientists compare results accurately across different trials and locations.^[15]

Clinical trials typically require documentation of at least two of the three classic features of the condition: fibrous dysplasia affecting multiple bones, café-au-lait skin spots with characteristic irregular borders, and evidence of excess hormone production from endocrine glands. Research protocols often specify exactly how these features must be documented to qualify for participation.^[22]

For bone involvement, trials usually require imaging confirmation through X-rays, CT scans, or MRI showing the characteristic patterns of fibrous dysplasia. Researchers may specify a minimum number of bones affected or require involvement of particular bone regions. Some studies focus specifically on craniofacial fibrous dysplasia, while others look at disease throughout the skeleton.^[21]

Documentation of skin findings for trial purposes typically involves detailed photographs of café-au-lait spots showing their location, size, and irregular borders. Some research protocols require that these spots follow the developmental lines of Blaschko on the body, reflecting the mosaic pattern of the underlying genetic mutation.^[5]

Endocrine abnormalities must be confirmed through specific hormone measurements in blood tests. For studies examining early puberty, researchers need documented evidence of elevated sex hormones along with physical signs of early sexual development. Thyroid studies require confirmation of hyperthyroidism with elevated thyroid hormone levels and often ultrasound images showing thyroid nodules or enlargement.^[16]

Many clinical trials also require genetic confirmation of the GNAS mutation, even though this can be challenging to detect. Research laboratories may use more sensitive testing methods than routine clinical tests, analyzing multiple tissue types or using specialized techniques to find the mutation in the mosaic pattern where it exists.^[14]

Screening for trial participation often includes baseline measurements that will be tracked throughout the study. These might include bone density scans to measure bone strength, detailed growth measurements in children, quality of life questionnaires, pain assessments, and comprehensive hormone panels. Having complete baseline data allows researchers to measure whether investigational treatments produce meaningful changes.^[15]

Some trials exclude patients with certain complications or prior treatments. For example, studies of new bone medications might not accept participants who have recently taken other bone-affecting drugs. Trials of treatments for early puberty typically require that participants haven’t yet completed puberty or reached their final adult height.^[11]

Age criteria vary depending on the study focus. Research examining childhood complications like early puberty naturally focuses on younger participants, while studies of adult bone disease or long-term outcomes enroll older individuals. Some longitudinal studies follow participants from childhood into adulthood to understand how the condition progresses over time.^[16]